قالب وردپرس درنا توس
Home / Business / Test manufacturer LumiraDx will be listed in a $5 billion SPAC transaction-Bloomberg

Test manufacturer LumiraDx will be listed in a $5 billion SPAC transaction-Bloomberg

April 7, 2021 Business 0 Views



  1. Test manufacturer LumiraDx will be publicly listed in a $5 billion SPAC transaction
  2. Next-generation point-of-care diagnostic testing company LumiraDx will be listed on NASDAQ through a merger with CA Healthcare Acquisition Corp
  3. View all reports from Google News

Source link

Powered by vaaju.com | Designed by vaaju
© Copyright 2021, All Rights Reserved